Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
- Author
- Lutz Nuhn (UGent) , Lien Van Hoecke (UGent) , Kim Deswarte (UGent) , Bert Schepens (UGent) , Yupeng Li, Bart Lambrecht (UGent) , Stefaan De Koker (UGent) , Sunil A David, Xavier Saelens (UGent) and Bruno De Geest (UGent)
- Organization
- Keywords
- RESPIRATORY SYNCYTIAL VIRUS, INNATE IMMUNE-RESPONSES, CANCER-IMMUNOTHERAPY, DENDRITIC CELLS, NANOPARTICLES, ACTIVATION, DELIVERY, TARGETS, 852A, Nanogels, TLR agonist, Vaccine, Lymph nodes, RSV
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.81 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8582258
- MLA
- Nuhn, Lutz, et al. “Potent Anti-Viral Vaccine Adjuvant Based on PH-Degradable Nanogels with Covalently Linked Small Molecule Imidazoquinoline TLR7/8 Agonist.” BIOMATERIALS, vol. 178, 2018, pp. 643–51, doi:10.1016/j.biomaterials.2018.03.026.
- APA
- Nuhn, L., Van Hoecke, L., Deswarte, K., Schepens, B., Li, Y., Lambrecht, B., … De Geest, B. (2018). Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. BIOMATERIALS, 178, 643–651. https://doi.org/10.1016/j.biomaterials.2018.03.026
- Chicago author-date
- Nuhn, Lutz, Lien Van Hoecke, Kim Deswarte, Bert Schepens, Yupeng Li, Bart Lambrecht, Stefaan De Koker, Sunil A David, Xavier Saelens, and Bruno De Geest. 2018. “Potent Anti-Viral Vaccine Adjuvant Based on PH-Degradable Nanogels with Covalently Linked Small Molecule Imidazoquinoline TLR7/8 Agonist.” BIOMATERIALS 178: 643–51. https://doi.org/10.1016/j.biomaterials.2018.03.026.
- Chicago author-date (all authors)
- Nuhn, Lutz, Lien Van Hoecke, Kim Deswarte, Bert Schepens, Yupeng Li, Bart Lambrecht, Stefaan De Koker, Sunil A David, Xavier Saelens, and Bruno De Geest. 2018. “Potent Anti-Viral Vaccine Adjuvant Based on PH-Degradable Nanogels with Covalently Linked Small Molecule Imidazoquinoline TLR7/8 Agonist.” BIOMATERIALS 178: 643–651. doi:10.1016/j.biomaterials.2018.03.026.
- Vancouver
- 1.Nuhn L, Van Hoecke L, Deswarte K, Schepens B, Li Y, Lambrecht B, et al. Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. BIOMATERIALS. 2018;178:643–51.
- IEEE
- [1]L. Nuhn et al., “Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist,” BIOMATERIALS, vol. 178, pp. 643–651, 2018.
@article{8582258,
author = {{Nuhn, Lutz and Van Hoecke, Lien and Deswarte, Kim and Schepens, Bert and Li, Yupeng and Lambrecht, Bart and De Koker, Stefaan and David, Sunil A and Saelens, Xavier and De Geest, Bruno}},
issn = {{0142-9612}},
journal = {{BIOMATERIALS}},
keywords = {{RESPIRATORY SYNCYTIAL VIRUS,INNATE IMMUNE-RESPONSES,CANCER-IMMUNOTHERAPY,DENDRITIC CELLS,NANOPARTICLES,ACTIVATION,DELIVERY,TARGETS,852A,Nanogels,TLR agonist,Vaccine,Lymph nodes,RSV}},
language = {{eng}},
pages = {{643--651}},
title = {{Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist}},
url = {{http://doi.org/10.1016/j.biomaterials.2018.03.026}},
volume = {{178}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: